MedTrace Logo

Evaluation of a New Invitation Procedure to the French Organized Colorectal Cancer Screening Program

NCT05589675 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64500

Last updated 2025-07-28

No results posted yet for this study

Summary

This is a randomized controlled trial comparing the effect on participation rates to colorectal cancer screening between an intervention arm (invitation letter to the screening program including a FIT test with or without prior notification) and a control arm with the standard of care (invitation letter to visit the GP who will deliver the FIT test).

Conditions

Interventions

OTHER

Dispatch of the screening test along the invitation letter to the national colorectal cancer screening program

The individuals eligible for the colorectal cancer screening program will receive at home an invitation letter to participate to the program along with a FIT test. The follow-up will be similar to the standard of care, i.e. reminder letters at 5 and 10 months if there is no participation, and reminders if no coloscopy after a positive FIT test

OTHER

Sending of a prior notification to the new entrants of the national program

Dispatch of a notification, one month prior the dispatch of the screening test along the invitation letter. This intervention is among the new entrants to the national program

Sponsors & Collaborators

  • International Agency for Research on Cancer

    lead OTHER

Principal Investigators

  • Maurice TANGUY, MD · Regional Cancer Screening Coordinating Centre, Meurthe-et-Moselle site, Nancy, France

  • Myriam GUERBAZ SOMMI, MD · Regional Cancer Screening Coordinating Centre, Moselle site, Metz, France

  • Jean BOTO KEKY, MD · Regional Cancer Screening Coordinating Centre, Ardennes site, Charleville-Mézières, France

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-07-17
Completion
2026-02-27

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05589675 on ClinicalTrials.gov